Tricuspid regurgitation and implantable devices

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 2, 2015, Pages 259-266

  Al Bawardy, Rasha ^a   Krishnaswamy, Amar ^b   Rajeswaran, Jeevanantham ^b   Bhargava, Mandeep ^b   Wazni, Oussama ^b   Wilkoff, Bruce ^b   Tuzcu, Emin Murat ^b   Martin, David ^b   Thomas, James ^b   Blackstone, Eugene ^b   Kapadia, Samir ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiac resynchronization therapy defibrillator (CRT D); implantable cardiac devices; implantable cardioverter defibrillator (ICD); permanent pacemaker (PPM); tricuspid regurgitation (TR); valvular heart disease

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; ADVERSE EFFECTS; EPIDEMIOLOGY; HEART DISEASES; INCIDENCE; MORTALITY; RISK ASSESSMENT; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRICUSPID VALVE INSUFFICIENCY; UNITED STATES;

DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OHIO; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL RATE; TRICUSPID VALVE INSUFFICIENCY;

EID: 84922650912     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12530     Document Type: Article

References (16)

1. Grenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: Increasing complexity of patients and procedures. J Am Coll Cardiol 2012; 60: 1540-1545.
2. Gibson TC, Davidson RC, DeSilvey DL,. Presumptive tricuspid valve malfunction induced by a pacemaker lead: A case report and review of the literature. Pacing Clin Electrophysiol 1980; 3: 88-95.
3. Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS,. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 1998; 82: 1130-1132, A9.
4. De Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser CA,. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: A clinical and echocardiographic study. Pacing Clin Electrophysiol 2000; 23: 423-426.
5. Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D,. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 2009; 32 (Suppl 1): S135-S137.
6. Webster G, Margossian R, Alexander ME, Cecchin F, Triedman JK, Walsh EP, Berul CI,. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 2008; 21: 65-68.
7. Kucukarslan N, Kirilmaz A, Ulusoy E, Yokusoglu M, Gramatnikovski N, Ozal E, Tatar H,. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads. J Card Surg 2006; 21: 391-394.
8. Leibowitz DW, Rosenheck S, Pollak A, Geist M, Gilon D,. Transvenous pacemaker leads do not worsen tricuspid regurgitation: A prospective echocardiographic study. Cardiology 2000; 93: 74-77.
9. Gillinov AM, McCarthy PM, Blackstone EH, Rajeswaran J, Pettersson G, Sabik JF, Svensson LG, et al. Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality. J Thorac Cardiovasc Surg 2005; 129: 1322-1329.
10. Diggle PJ, Heagerty PJ, Liang KY, Zeger SL,. Analysis of Longitudinal Data. 2nd Ed. New York, Oxford University Press, 2002.
11. Blackstone EH,. Breaking down barriers; helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 2001; 122: 430-439.
12. Blackstone EH, Naftel DC, Turner ME Jr,. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986; 81: 615-624.
13. Breiman L,. Bagging predictors. Machine Learn 1996; 24: 123-140.
14. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR,. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: An observational study. J Am Soc Echocardiogr 2008; 21: 284-287.
15. Celiker C, Küçükoglu MS, Arat-Ozkan A, Yazicioglu N, Uner S,. Right ventricular and tricuspid valve function in patients with two ventricular pacemaker leads. Jpn Heart J 2004; 45: 103-108.
16. Postaci N, Eksi K, Bayata S, Yeşil M., Effect of the number of ventricular leads on right ventricular hemodynamics in patients with permanent pacemaker. Angiology 1995; 46: 421-424.